Immunogen Inc (IMGN)

Trade IMGN now with

RTTNews Articles

Date	Headline
4/26/2013 7:34:19 AM	ImmunoGen Q3 Loss Narrows, Beats Estimates
4/26/2013 7:00:29 AM	Immunogen Q3 13 Earnings Conference Call At 8:00 AM ET
4/26/2013 6:37:55 AM	ImmunoGen Q3 Loss/Shr $0.02 Vs. Loss $0.24 Last Year
4/10/2013 11:12:06 PM	AEZS, BLRX Move Up, ASTX, PFE Hit New Highs, ACT Buys Peace, MEIP To Watch Out
4/10/2013 8:14:15 AM	ImmunoGen Reports Preclinical Data For EGFR-targeting ADC, IMGN289 - Quick Facts
4/10/2013 8:05:07 AM	ImmunoGen Discloses Preclinical Data For Its EGFR-targeting ADC, IMGN289
3/5/2013 9:00:47 AM	Immunogen To Present At Cowen & Co. Conference; Webcast At 10:00 AM ET
2/26/2013 9:30:21 AM	Immunogen To Present At RBC Capital Markets Conference; Webcast At 10:30 AM ET
2/25/2013 10:05:21 AM	Immunogen To Present At Citi Healthcare Conference; Webcast At 11:05 AM ET
2/22/2013 12:35:15 PM	FDA Approves Genentech's Kadcyla For Late-stage Breast Cancer
2/22/2013 9:53:25 AM	FDA Approves Genentech's Kadcyla For Late-stage Metastatic Breast Cancer
2/22/2013 9:36:48 AM	Immunogen Trading Expected To Resume At 10:00 AM ET
2/22/2013 9:32:10 AM	ImmunoGen Announces FDA Approval Of Kadcyla
2/22/2013 9:22:23 AM	Immunogen Trading Halted; Pending News
2/12/2013 8:00:20 AM	Immunogen To Present At BIO CEO & Investor Conference; Webcast At 9:00 AM ET
2/12/2013 6:40:53 AM	ImmunoGen Completes Patient Enrollment In IMGN901 NORTH Trial - Quick Facts
2/12/2013 6:30:38 AM	ImmunoGen Completes Patient Enrollment In First Stage Of NORTH Two-stage Phase II Trial
1/25/2013 7:24:40 AM	ImmunoGen Posts Wider-than-expected Q2 Loss; Backs FY13 Loss View
1/25/2013 7:12:06 AM	ImmunoGen Q2 Loss Wider, Below Estimates, Reaffirms 2013 Outlook
1/25/2013 6:59:35 AM	Immunogen Q2 13 Earnings Conference Call At 8:00 AM ET

Previous 20 Headlines